TH seems overkill but great news for MXC, real progress
The registration and sale of a pharmaceutical product for the treatment of epilepsy presents a substantial commercial opportunity for MGC Pharmaceuticals. A registered pharmaceutical grade product has the potential to bring relief to millions of epilepsy sufferers across the globe. In Europe alone, there are close to 1 million children and young people with epilepsy and a further 2 million people aged between 20-64 suffering from epilepsy. Each year it is estimated that there are 130,000 new cases of epilepsy among children and adolescents in Europe1.
- Forums
- ASX - By Stock
- Ann: Medical Cannabis Clinical Study Commencing
TH seems overkill but great news for MXC, real progress The...
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
0.005(1.79%) |
Mkt cap ! $13.79M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 28.5¢ | $99 | 347 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14314 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14314 | 0.280 |
1 | 7100 | 0.275 |
3 | 23700 | 0.270 |
1 | 18000 | 0.265 |
1 | 2000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 1000 | 1 |
0.310 | 6587 | 2 |
0.370 | 1056 | 1 |
0.380 | 1047 | 1 |
0.385 | 8000 | 1 |
Last trade - 11.04am 26/07/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |